ICA-121431

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameICA-121431

Drug Alias NameICA-121431

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSodium channel protein type III alpha subunit blockersSodium channel protein type I alpha subunit blockersSodium channel protein type IX alpha subunit blockers

TargetsSodium channel protein type I alpha subunitSodium channel protein type IX alpha subunitSodium channel protein type III alpha subunit

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIcagen Inc

China Registration ClassN/A

Develop Information

Active CompaniesIcagen Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A